Updated time: 2023-05-29 10:27:59
14A-1030312、14A-1030312B
CN ZL2015 8 0030480.9
This invention creates a new class of sesquiterpene derivatives which are organically semi-synthesized based on a natural phytoagent for treatment of cancerous and inflammatory diseases. The novel chemical derivatives can prevent or suppress orthotopic and metastatic mammary tumor or melanoma growth and activity in mice. In addition, the novel compound(s) can function synergistically with the current chemotherapeutic drugs. Notably, the novel compound(s) can sensitize chemotherapeutic drug in treating drug resistant cancer cells, and also reduce chemotherapeutic drug caused side effects.
The advantages of this invention is that the created new compounds can modulate multiple targets or pathways in the cancer cells or within different cancer types consequently inhibit cancer cell activity and metastasis that is more beneficial and effective than the current targeted therapeutic drugs, which can only specifically treat a particular type of cancer. The novel compound(s) are effective to breast cancer, melanoma, lung cancer, prostate cancer, kidney cancer, brain cancer, colon cancer, etc. The broadly usage and application of the invented compound(s) in this invention are anticipated. In addition, this invention also provides an adjuvant or alternative approach by using the novel compound(s) to overcome drug resistance or side effects induced by current chemotherapeutic drugs, such as Vemurafenib induced cutaneous squamous-cell carcinoma in patients.
- The novel plant-based compounds created in the invention can be developed as drug to prevent or complementary/alternative control the situations of human disorders, such as malignant disease or inflammation.
- Pharmaceutical or biotech industry.
Lie-Fen Shyur, Kuo-Hsiung Lee, Kyoko Nakagawa-Goto, ...
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Novel sesquiterpene derivatives and their use in inflammation or cancer treatment